Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Go East, young biomed company
Globes, Israel
Sunday, September 14, 2008 - 12:08pm
tags:
Bayer CEO says not vulnerable to takeover-paper
Forbes
Sunday, September 14, 2008 - 12:06pm
tags:
China Biopharma Week in Review: Broad Views, Individual Companies
Seeking Alpha
Sunday, September 14, 2008 - 12:05pm
tags:
Teva Says U.S. Court Denies It Risperdal Exclusivity
Bloomberg
Sunday, September 14, 2008 - 12:04pm
tags:
Spine tingler: Is Medtronic money swaying surgeons? 8 Minnesota doctors among those named in federal lawsuit
Pioneer Press, MN
Sunday, September 14, 2008 - 12:04pm
tags:
RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors
Yahoo
Saturday, September 13, 2008 - 12:47pm
tags:
Development Focus Pays Off For Biotech
Yahoo/Investor's Business Daily
Saturday, September 13, 2008 - 12:46pm
tags:
Fitch affirms 'A+' ratings for Bristol-Myers
Forbes
Saturday, September 13, 2008 - 12:45pm
tags:
Cerimon reports positive results from Phase II study of topical pain patch
Pharmaceutical Business Review
Saturday, September 13, 2008 - 12:43pm
tags:
Cyclacel expands Phase II sapacitabine trial to include MDS patients
Pharmaceutical Business Review
Saturday, September 13, 2008 - 12:42pm
tags:
Calando Pharmaceuticals initiates Phase II ovarian cancer study
Pharmaceutical Business Review
Saturday, September 13, 2008 - 12:41pm
tags:
Jazz Pharmaceuticals completes first Phase III study of fibromyalgia drug
Pharmaceutical Business Review
Saturday, September 13, 2008 - 12:40pm
tags:
Tianyin Pharmaceutical wins Chinese approval for asthma drug
Pharmaceutical Business Review
Saturday, September 13, 2008 - 12:39pm
tags:
BioLink shifts strategy to making drugs
San Antonio Business Journal, TX
Saturday, September 13, 2008 - 12:38pm
tags:
Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
CNW Telbec
Saturday, September 13, 2008 - 12:36pm
tags:
J&J's pharma chief leaving in'09
Star-Ledger, NJ
Saturday, September 13, 2008 - 12:36pm
tags:
Biopharmaceutical firm Catalyst Pharmaceutical to sell shares
Miami Herald, FL
Saturday, September 13, 2008 - 12:32pm
tags:
Patent for Stem Cell Breakthrough Awarded to Japanese University
MedIndia
Saturday, September 13, 2008 - 12:28pm
tags:
Vaccine against HER2-positive breast cancer offers complete protection in lab
WKYC-TV, OH
Saturday, September 13, 2008 - 12:26pm
tags:
Health Winners & Losers: Gilead
Yahoo/TheStreet.com
Friday, September 12, 2008 - 6:49pm
tags:

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.